Sangani Hospital

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0OVI01010
  • NSEID: SANGANI
  • BSEID:
INR
48.50
1.5 (3.19%)
BSENSE

Jan 19

BSE+NSE Vol: 1500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.5 k (-92.19%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

73.22%

When is the next results date for Sangani Hospital?

06-Jun-2025

No Upcoming Board Meetings

Has Sangani Hospital declared dividend?

06-Jun-2025

No Dividend History Available

What is the technical trend for Sangani Hospital?

09-Jun-2025

As of May 3, 2025, Sangani Hospital's technical trend is mildly bullish, though mixed signals from various indicators suggest caution.

As of 3 May 2025, the technical trend for Sangani Hospital has changed from bullish to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands suggest a mildly bearish outlook. The weekly KST is bullish, but the overall weekly indicators, including OBV, are mildly bearish. The lack of signals from the RSI on both weekly and monthly time frames further supports a neutral stance in momentum. Overall, the current technical stance is mildly bullish, but with caution due to mixed signals across different indicators.

View full answer

Who are the peers of the Sangani Hospital?

16-Jul-2025

Sangani Hospital's peers include KHFM Hospitality, Maitreya Medica, Vaidya Sane, and others, with varying management risks and growth ratings. Sangani Hospital has a 1-year return of 45.05%, lower than Maitreya Medica's 119.67% but higher than Nidan Laborator's -41.34%.

Peers: The peers of Sangani Hospital are KHFM Hospitality, Maitreya Medica., Vaidya Sane, Lotus Eye Hospit, Aatmaj Health, Nidan Laborator., Fortis Malar, Shanmuga Hos., and KK Shah Hospital.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shanmuga Hos., while Average management risk is found at KHFM Hospitality, Maitreya Medica., and Lotus Eye Hospit, and the rest. Below Average management risk is present at Vaidya Sane, Sangani Hospital, Aatmaj Health, Nidan Laborator., Fortis Malar, KK Shah Hospital, and the rest. Growth is rated as Good for Vaidya Sane and Aatmaj Health, while Below Average growth is noted for KHFM Hospitality, Maitreya Medica., Lotus Eye Hospit, Sangani Hospital, Nidan Laborator., Fortis Malar, and the rest. Capital Structure is rated as Excellent at Shanmuga Hos., Good at Maitreya Medica., Vaidya Sane, Lotus Eye Hospit, Sangani Hospital, Aatmaj Health, and KK Shah Hospital, and Below Average at Nidan Laborator. and Fortis Malar.<BR><BR>Return Snapshot: Maitreya Medica. has the highest 1-year return at 119.67%, while Nidan Laborator. has the lowest at -41.34%. Sangani Hospital's 1-year return of 45.05% is significantly higher than Nidan Laborator. but lower than Maitreya Medica. Additionally, Aatmaj Health, Nidan Laborator., Fortis Malar, and KK Shah Hospital all have negative six-month returns.

View full answer

What does Sangani Hospital do?

17-Jul-2025

Sangani Hospitals Ltd is a multi-speciality hospital in Keshod, Gujarat, providing primary to tertiary care. It was incorporated in November 2021 and has a market cap of INR 91 Cr, with no recent revenue or profit data available.

Overview:<BR>Sangani Hospitals Ltd operates as a multi-speciality hospital providing primary, secondary, and tertiary care facilities, and is categorized as a micro-cap company in the hospital industry.<BR><BR>History:<BR>Sangani Hospitals Ltd was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021. The company received its Certificate of Incorporation on November 12, 2021, and its Certificate of Commencement of Business on December 14, 2021. Revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 91 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 35.00<BR>Industry P/E: 59<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.57<BR>Return on Equity: 7.73%<BR>Price to Book: 2.71<BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Who are the top shareholders of the Sangani Hospital?

17-Jul-2025

The top shareholders of Sangani Hospital include Ajaykumar Natavarlal Sangani with 24.04%, individual investors with 24.3%, and Affluence Gems Private Limited as the largest public shareholder at 2.18%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Sangani Hospital include the promoters, with Ajaykumar Natavarlal Sangani holding the largest share at 24.04%. In addition, individual investors collectively hold 24.3% of the shares. The highest public shareholder is Affluence Gems Private Limited, which owns 2.18%. There is also one Foreign Institutional Investor (FII) that holds a small stake of 0.02%. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

View full answer

How big is Sangani Hospital?

24-Jul-2025

As of 24th July, Sangani Hospitals Ltd has a market capitalization of 89.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 33.49 Cr and Total Assets of 35.41 Cr; however, there is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Sangani Hospitals Ltd has a market capitalization of 89.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 33.49 Cr and Total Assets totaling 35.41 Cr.

View full answer

How has been the historical performance of Sangani Hospital?

15-Nov-2025

Sangani Hospital has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25. However, operating profit margins have decreased, and cash flow from operations has declined, indicating challenges in maintaining financial stability.

Answer:<BR>The historical performance of Sangani Hospital shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Sangani Hospital's net sales increased from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25, indicating a positive trend in revenue generation. The total operating income followed a similar trajectory, rising from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25. The total expenditure, excluding depreciation, also grew from 12.62 Cr in Mar'23 to 18.73 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) rose from 3.14 Cr in Mar'23 to 4.07 Cr in Mar'25, although the operating profit margin decreased from 19.46% in Mar'23 to 11.61% in Mar'25. Profit before tax showed an upward trend, increasing from 2.02 Cr in Mar'23 to 3.46 Cr in Mar'25, while profit after tax also rose from 1.48 Cr to 2.59 Cr during the same period. The consolidated net profit slightly decreased from 2.70 Cr in Mar'24 to 2.59 Cr in Mar'25. On the balance sheet, total assets increased significantly from 19.60 Cr in Mar'23 to 39.18 Cr in Mar'25, with total liabilities also rising from 19.60 Cr to 39.18 Cr. Cash flow from operating activities showed a decline from 3.00 Cr in Mar'24 to 2.00 Cr in Mar'25, contributing to a net cash outflow of 1.00 Cr in Mar'25. Overall, while Sangani Hospital has demonstrated growth in sales and profits, it faces challenges in maintaining operating margins and cash flow stability.

View full answer

Is Sangani Hospital overvalued or undervalued?

25-Nov-2025

As of November 24, 2025, Sangani Hospital is considered undervalued and attractive compared to its peers, with a PE ratio of 33.75, despite a year-to-date return of -12.96%.

As of 24 November 2025, Sangani Hospital's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially in comparison to its peers. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 32.87, and a ROE of 6.98%. <BR><BR>When compared to its peers, Sangani Hospital stands out as more attractive than Max Healthcare, which has a PE ratio of 79.41 and is deemed very expensive, and Narayana Hrudaya, which has a PE of 47.49 and is classified as expensive. Despite recent underperformance, with a year-to-date return of -12.96% compared to the Sensex's 9.79%, the valuation metrics suggest that Sangani Hospital presents a compelling investment opportunity in the current market.

View full answer

Why is Sangani Hospitals Ltd falling/rising?

19-Jan-2026

As of 18-Jan, Sangani Hospitals Ltd's stock is rising by 1.73% today, but it has faced significant declines of 20.61% over the past month and 32.57% over the past year. Despite today's gains, the stock is below its moving averages and has hit a new 52-week low, indicating ongoing challenges and reduced investor participation.

As of 18-Jan, Sangani Hospitals Ltd's stock price is currently rising, with a change of 0.8, representing a 1.73% increase. However, it is important to note that the stock has experienced significant declines over various periods, including a 20.61% drop over the past month and a 32.57% decrease over the past year. <BR><BR>Despite today's positive movement, the stock is trading below its moving averages across multiple time frames, indicating a general downtrend. Additionally, the stock hit a new 52-week low of Rs.43.9 today, which suggests ongoing challenges. The delivery volume has also seen a drastic decline of 86.96% compared to the 5-day average, indicating falling investor participation. <BR><BR>While today's performance has outperformed the sector by 2.69%, the overall trend and historical performance suggest that the stock is still facing significant headwinds.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 65 Cr (Micro Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.18

stock-summary
Return on Equity

6.98%

stock-summary
Price to Book

1.75

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.24%
0%
-26.24%
6 Months
-27.18%
0%
-27.18%
1 Year
-30.52%
0%
-30.52%
2 Years
24.36%
0%
24.36%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Sangani Hospital for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Why is Sangani Hospitals Ltd falling/rising?

Persistent Underperformance Against Benchmarks

Examining the stock’s returns relative to the Sensex reveals a stark contrast. Over the past week, Sangani Hospitals has declined by 9.47%, substantially underperforming the Sensex’s modest 2.45% fall. This negative trend extends over longer periods, with the stock down 12.95% in the last month compared to the Sensex’s 0.61% decline. Year-to-date, the stock has fallen nearly 10%, while the benchmark index has only dipped 1.71%. Most notably, over the past year, Sangani Hospitals has plummeted 35.43%, whereas the Sensex has gained 9.17%. These figures underscore a pronounced weakness in the stock’s performance relative to the broader market, signalling investor concerns specific to the company or its sector.

Technic...

Read full news article

Is Sangani Hospital overvalued or undervalued?

Valuation Metrics and Financial Health

Sangani Hospital trades at a price-to-earnings (PE) ratio of approximately 33.75, which is moderate within the healthcare sector. Its price-to-book value stands at 2.36, indicating that the market values the company at more than twice its net asset value. The enterprise value to EBITDA ratio is around 32.87, reflecting the company’s earnings before interest, taxes, depreciation, and amortisation relative to its overall valuation. These multiples suggest a balanced valuation, especially when considering the hospital’s return on capital employed (ROCE) of 6.09% and return on equity (ROE) of 6.98%, which, while positive, are modest and indicate moderate profitability.

Peer Comparison Highlights

When compared t...

Read full news article

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.30%
EBIT Growth (5y)
-2.33%
EBIT to Interest (avg)
2.20
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.57
Tax Ratio
25.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.21%
ROE (avg)
7.18%

Valuation key factors

Factor
Value
P/E Ratio
25
Industry P/E
0
Price to Book Value
1.75
EV to EBIT
31.29
EV to EBITDA
23.66
EV to Capital Employed
1.91
EV to Sales
2.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.09%
ROE (Latest)
6.98%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ajaykumar Natavarlal Sangani (24.04%)

Highest Public shareholder

Jaggaraju Satyavenkata Gurajapu (1.48%)

Individual Investors Holdings

23.65%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sangani Hospital"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 83.09% vs 11.69% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 12.36% vs -47.95% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20.47",
          "val2": "11.18",
          "chgp": "83.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.42",
          "val2": "0.76",
          "chgp": "86.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.00",
          "val2": "0.89",
          "chgp": "12.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.94%",
          "val2": "6.80%",
          "chgp": "0.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sangani Hospital"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 35.14% vs 0.06% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -4.07% vs 82.43% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.19",
          "val2": "15.68",
          "chgp": "35.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.46",
          "val2": "3.08",
          "chgp": "-20.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.59",
          "val2": "2.70",
          "chgp": "-4.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.61%",
          "val2": "19.64%",
          "chgp": "-8.03%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Mar'25
Change(%)
Net Sales
20.47
11.18
83.09%
Operating Profit (PBDIT) excl Other Income
1.42
0.76
86.84%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.00
0.89
12.36%
Operating Profit Margin (Excl OI)
6.94%
6.80%
0.14%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 83.09% vs 11.69% in Mar 2025

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 12.36% vs -47.95% in Mar 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
21.19
15.68
35.14%
Operating Profit (PBDIT) excl Other Income
2.46
3.08
-20.13%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.59
2.70
-4.07%
Operating Profit Margin (Excl OI)
11.61%
19.64%
-8.03%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 35.14% vs 0.06% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -4.07% vs 82.43% in Mar 2024

stock-summaryCompany CV
About Sangani Hospitals Ltd stock-summary
stock-summary
Sangani Hospitals Ltd
Micro Cap
Hospital
Sangani Hospitals Limited was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021, through Certificate of Incorporation dated November 12, 2021 and Certificate of Commencement of Business dated December 14, 2021 issued by the Registrar of Companies, Ahmedabad. Sangani Group is a healthcare organization founded by the Promoter, Dr. Ajaykumar Sangani. Sangani Hospital is 36 beds multi-speciality hospital with primary, secondary and tertiary care facilities.
Company Coordinates stock-summary
Icon
No Company Details Available